# Kisspeptin-10: The Shorter Isoform in Research

> Kisspeptin-10 is the ten-residue isoform — about 1302.5 Da, a ~4-minute half-life, a fast sharp LH signal in men. The pharmacology of the short bright flare, cited.

Ten residues, a four-minute half-life, a fast LH rise — the pharmacology of the brief flare, read against its longer sibling.

## The short version

Kisspeptin-10 is the short form of the kisspeptin family — just ten amino acids, the tail end of the larger molecule. It is the part the receptor actually grabs, so even this small fragment switches the reproductive signal on. Two things define it: it is *fast* and it is *brief*. Given to healthy men, it pushed LH (a hormone that drives testosterone) up within half an hour. But it clears from the blood in about four minutes, so its effect is a quick flare rather than a long glow. That short life has an upside — because the signal does not linger, the receptor is less likely to tire out (the fading effect called tachyphylaxis). On this page, kisspeptin-10 is set side by side with the longer kisspeptin-54 so the difference between the brief flare and the longer burn is easy to see. Like everything here, it is investigational and described in research terms only.

## What kisspeptin-10 is

Kisspeptin-10 (KP-10) is the ten-residue C-terminal fragment of the KISS1 gene product, with the sequence `Tyr-Asn-Trp-Asn-Ser-Phe-Gly-Leu-Arg-Phe-NH2` and a molecular weight of about `1302.5 Da` [3]. Like every active kisspeptin fragment it carries the conserved Arg-Phe-amide tail that KISS1R reads, which is why the short fragment retains full receptor activity. It binds the same receptor — KISS1R, the former GPR54 — on hypothalamic GnRH neurons, and fires the same Gq/PLC/IP3-calcium cascade that depolarizes them [2]. In short, kisspeptin-10 is the minimal signal: the smallest piece that still wakes the axis.

## The pharmacokinetics: a four-minute flare

The signature of kisspeptin-10 is speed. Its functional plasma half-life in humans is roughly `4 minutes` — plasma peptidases clear the short peptide quickly [3]. That makes its signal sharp and short-lived: it rises fast and falls fast. Mechanistic work comparing the isoforms at equimolar doses found kisspeptin-10 reaches lower peak levels and sustains LH release for a shorter time than kisspeptin-54, a difference attributed to KP-10's lesser resistance to peptidase cleavage [11]. The flip side is sensitivity: because the brief flare does not hold the receptor open, receptor desensitization may be better avoided with the short isoform under well-spaced or pulsatile protocols [11].

## Kisspeptin-10 in humans: the LH and testosterone signal

In healthy men, intravenous kisspeptin-10 produced maximal LH stimulation at a `1 µg/kg` bolus, raising LH from `4.1` to `12.4 IU/L` at 30 minutes; continuous infusion at `1.5 µg/kg/h` raised mean LH from `5.2` to `14.1 IU/L` and lifted LH pulse frequency from `0.7` to `1.0 pulses/h`, while a higher `4 µg/kg/h` infusion raised serum testosterone from `16.6` to `24.0 nmol/L` [3]. A direct head-to-head infusion in healthy men found kisspeptin-10 and kisspeptin-54 produced comparable acute gonadotropin responses at matched infusion rates — both stimulate LH and FSH through the GnRH axis, and at the moment of action the short and long forms point the same way [9]. The isoform difference shows up not in the direction of the signal but in how long it lasts.

---

A noir reading of the Kisspeptin record — one upstream signal traced from KISS1 to GnRH and logged where the trials confirm it, the brief KP-10 flare set apart from the longer KP-54 burn, the fading-with-overuse and not-approved, not-a-supplement truths held in the light; no clinic behind the pulse, and nothing here dosed, dispensed, or sold.